NCT02351752View on ClinicalTrials.gov

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Primary IgA Nephropathy

Interventions

DRUG

Hydroxychloroquine Sulfate

Hydroxychloroquine Sulfate: 0.1 Tid(eGFR 30-59);0.2 Bid (eGFR\>60)

Trial Locations (1)

100034

Peking University First Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LLiu

OTHER